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Acute kidney injury (AKI) is common after cardiac arrest and targeted temperature 49 
management (TTM). The impact of different lengths of cooling on the development of AKI 50 
has not been well studied. In this study of patients included in a randomised controlled trial of 51 
TTM at 33°C for 24 versus 48 hours after cardiac arrest (TTH48 trial), we examined the 52 
influence of prolonged TTM on AKI and the incidence and factors associated with the 53 




This study was a sub-study of the TTH48 trial, which included patients cooled to 33±1˚C after 58 
out-of-hospital cardiac arrest for 24 versus 48 hours. AKI was classified according to the 59 
KDIGO AKI criteria based on serum creatinine and urine output collected until ICU discharge 60 
for a maximum of seven days. Survival was followed for up to six months. The association of 61 
admission factors on AKI was analysed with multivariate analysis and the association of AKI 62 
on mortality was analysed with Cox regression using the time to AKI as a time-dependent 63 




Of the 349 patients included in the study, 159 (45.5%) developed AKI. There was no 68 
significant difference in the incidence, severity or time to AKI between the 24- and 48-hour 69 
groups. Serum creatinine values had significantly different trajectories for the two groups with 70 
a sharp rise occurring during rewarming. Age, time to return of spontaneous circulation, 71 
serum creatinine at admission and body mass index were independent predictors of AKI. 72 
Patients with AKI had a higher mortality than patients without AKI (hospital mortality 36.5% 73 















We did not find any association between prolonged TTM at 33°C and the risk of AKI during 80 
the first seven days in the ICU. AKI is prevalent after cardiac arrest and TTM and occurs in 81 
almost half of all ICU admitted patients and more commonly in the elderly, with an increasing 82 
BMI and longer arrest duration. AKI after cardiac arrest is an independent predictor of time to 83 










Trial registration 94 
















Acute kidney injury (AKI) is a well-known complication in post-cardiac arrest patients [1]. 111 
Recent studies have found an incidence of AKI of more than 40% when modern staging of 112 
AKI was used and targeted temperature management (TTM) implemented as standard post-113 
resuscitation care [1, 2]. The development of renal dysfunction in this setting is most likely 114 
due to local and whole body ischemia and reperfusion injury as well as circulatory failure in 115 
the post-resuscitation period [3]. This post-cardiac arrest syndrome is characterised by 116 
immunological, inflammatory and coagulation disturbances leading to perfusion disturbances 117 
and organ dysfunction. Although prognosis after successful resuscitation is mainly linked to 118 
the presence of hypoxic-ischemic brain injury, extra-cerebral organ dysfunction in the 119 
immediate post-resuscitation period has been shown to have prognostic implications [4]. 120 









Baseline renal insufficiency and post-resuscitative AKI have both been recognised as 121 
independent predictors of mortality and poor neurological outcome. The direct effect of AKI 122 
on the central nervous system has not been fully elucidated, but increased inflammation and 123 
oxidative stress in the brain have also been shown in experimental models of AKI [5]. 124 
Hypothermia preceding ischemia has an established role in organ protection, but the 125 
impact of post-cardiac arrest TTM on renal outcomes is less clear. A meta-analysis of 19 trials 126 
of TTM after cardiac arrest, brain injury or major cardiac surgery did not show a reduction in 127 
AKI when TTM was performed [6]. Even if TTM has the potential for renal protection 128 
through mechanisms such as the reduction of metabolic demand, oxidative stress and 129 
apoptosis, some potentially disadvantageous effects of TTM are present. A frequent 130 
observation is ‘cold diuresis’, which most likely occurs due to a combination of increased 131 
venous return, hormonal changes and tubular dysfunction and may cause hypovolemia if 132 
volume replacement is insufficient.  133 
The potential modulating effect of various approaches to TTM on renal function has 134 
not been well studied. In particular, the impact of the length of cooling on renal function has 135 
not been addressed. In this study, we investigated the impact of 24 or 48 hours of TTM on the 136 
incidence of AKI in patients suffering from out-of-hospital cardiac arrest (OHCA). 137 
Secondarily, we studied factors associated with the development of AKI and the impact of 138 






Study design 145 
 146 
The study is a preplanned explorative analysis of AKI in patients included in a multinational 147 
randomised, controlled trial on the effect of 48 compared to 24 hours of TTM after OHCA of 148 
a presumed cardiac origin (TTH48) . The details of the TTH48 study including inclusion and 149 
exclusion criteria have previously been published elsewhere [8, 9]. In brief, TTM for 24 150 
versus 48 hours with a target of 33±1˚C was performed from hospital arrival as per local 151 
protocol, utilising cold fluids, surface cooling and intravascular cooling devices. 152 
Randomisation was performed during the first 24 hours of cooling.  153 









The study was approved by the ethics committee in each participating centre or country. The 154 
study was conducted according to the requirements of the Declaration of Helsinki; written 155 
informed consent was obtained from the next of kin or a legal surrogate before randomisation 156 




Hypothermia at 33±1˚C was maintained for either 24 or 48 hours according to randomisation 161 
and rewarming performed at a maximum of 0.5˚C/h. A urinary catheter with a thermistor 162 
measured bladder temperature and provided feedback to the temperature management 163 
systems. Sedation was maintained with propofol/midazolam and remifentanil/fentanyl 164 
infusions. Shivering was treated with increased sedation or cisatracurium. Noradrenaline was 165 




From February 2013 to June 2016, 355 patients were randomised and included in the trial.   170 
Study population characteristics included sex, age, body mass index (BMI) and previous 171 
medical history as well as prehospital data followed the Utstein template recommendation. 172 
Pre-ICU in-hospital data included data from admission to the emergency department and from 173 
cardiac catherisation laboratories.  Data on serum creatinine (sCr), serum urea (sUr), urinary 174 
output (UO) and the need for renal replacement therapy (RRT) were prospectively collected 175 
for seven days or until ICU discharge, depending on which occurred first. Follow-up for 176 
survival was a minimum of 180 days. Data were managed using REDCap electronic data 177 
capture tools. 178 
 179 
 180 
AKI classification 181 
 182 
Due to the lack of hourly UO, we used a modified KDIGO AKI classification based on sCr 183 
and daily UO averaged over 24 hours[2]. We estimated the baseline sCr using the MDRD 184 
equation assuming a glomerular filtration rate (eGFR) of 75 for all patients [10]. The different 185 
stages of AKI were defined as follows: Stage 1: A 1.5- to 1.9-fold increase in sCr compared to 186 
the estimated baseline sCr or an absolute increase of more than 26.5 µmol/l within 48 hours. 187 









Stage 2: A 2.0- to 2.9-fold increase in sCr compared to the estimated baseline sCr or a UO of 188 
less than 0.5 ml/kg/hour for the last 24 hours. Stage 3: A threefold increase in sCr compared 189 
to the estimated baseline sCr, an increase in sCr to more than 353.6 µmol/l, a UO of less than 190 
0.3 ml/kg/hour for the last 24 hours or the initiation of RRT. 191 
 192 
 193 
Statistical analysis 194 
 195 
Categorical variables were expressed as counts (percentages) and continuous variables as 196 
means ± SD or medians (IQR). Admission factors were compared using Student’s t-test, chi-197 
square test and Fischer exact test as appropriate. Factors with a p-value < 0.1 in the univariate 198 
analysis were included in the multivariate analysis. The difference in the time to AKI between 199 
patients in the 24- and 48-hour cooling groups was assessed using the log-rank test. Cox 200 
regression analysis was performed to assess independent predictors of the time to AKI. 201 
Independent predictors of mortality at six months were performed using Cox regression 202 
analysis with the time to AKI as a time-dependent covariate. The impact of the cooling length 203 
on sCr levels was assessed using a mixed linear model. Statistical analysis was performed 204 
with SPSS for Windows v.24.0 (IBM Corp., Armonk, NY) and SAS v. 9.4. (SAS Institute 205 




Included patients and the incidence of AKI  210 
 211 
 A total of 355 patients were randomised in the trial. Two patients withdrew consent, one 212 
patient was lost to follow-up and one was incorrectly randomised. Of the 351 patients who 213 
completed the trial, two were excluded due to chronic dialysis, leaving 349 patients for AKI 214 
analysis (Fig. 1); 159 patients (45.5%) were classified as having AKI during their ICU stay 215 
(KDIGO AKI 1-3), and 24 patients (6.9%) received RRT. Of the 159 patients who developed 216 
AKI, 79 (49.7%) did not have AKI at ICU discharge or day 7 in the ICU. 217 
 218 
Difference between 48- and 24-hour cooling 219 
 220 









The duration of hypothermia did not affect the incidence or severity of AKI. Seventy-eight 221 
(44.3%) patients in the 24-hour cooling group developed AKI versus 81 (46.8%) in the 48-222 
hour cooling group, (p=0.639). In addition, there was no difference in the time to AKI in 223 
patients treated with 48 compared to 24 hours of cooling in either univariate (HR 0.97, 95% 224 
CI 0.71-1.32, p=0.85) or multivariate analysis (HR 1.02 95% CI 0.74-1.41, p=0.89).   225 
 226 
Among the patients with AKI, there was no significant difference in the severity of AKI (2.0 227 
vs 2.2, p=0.13) or the time to development of AKI between the two groups. The time to AKI 228 
was 1.5 (1.3–1.7) days in the 24-hour cooling group and 1.8 (1.5–2.1) days in the 48-hour 229 
cooling group (p=0.66). The cumulative number of AKI is shown in Fig. 2. The length of 230 
cooling had a significant impact on the development of sCr values during the observation 231 
period (p<0.05) (Fig 3). Data on the sCr, sUr, daily UO and fluid balance for the first 72 hours 232 
of the ICU stay are provided in Supplemental Table 1. 233 
 234 
Admission factors for AKI 235 
There were several differences in patient characteristics, factors at resuscitation and admission 236 
between the patients that developed AKI compared to those who did not develop AKI. 237 
Notably, AKI patients were older, had a higher BMI, more commonly had diabetes and had a 238 
higher sCr level at ICU admission (Table 1). Regarding factors at resuscitation, patients who 239 
developed AKI had a longer time to return of spontaneous circulation (ROSC) and more 240 
commonly received both adrenaline and amiodarone (Table 1). In a multivariate analysis of 241 
risk factors at ICU admission for the development of AKI, we found age, BMI, sCr at ICU 242 
admission and time to ROSC to be independent predictors of AKI (Table 2).   243 
 244 
Association between AKI and outcome 245 
 246 
Patients who developed AKI had a higher ICU- (25.2% vs 7.9%, p<0.001), hospital- (36.5% 247 
vs 12.5%, p<0.001) and six-month mortality (45.9% vs 16.8%, p<0.001), than those who did 248 
not develop AKI. Survival curves are provided in Supplemental Figure 1. In a Cox regression 249 
model including KDIGO AKI as a time-dependent covariate, AKI was a significant predictor 250 
of mortality. However, patients with KDIGO AKI 1 did not have significantly greater risk 251 
than patients without kidney injury (Table 3). Other significant predictors of mortality were 252 
age, time to ROSC and non-shockable rhythm. 253 









Patients with AKI also had a longer ICU but not hospital stay compared to patients without 254 







In this study of 349 patients from the TTH-48 randomised controlled trial with data 262 
collection of creatinine levels and UO over the first seven days, we found that AKI was 263 
common after cardiac arrest and associated with a higher age, a higher BMI and a longer time 264 
to ROSC.  265 
We did not find a significant effect of the length of cooling after cardiac arrest on AKI 266 
evaluated by the KDIGO AKI criteria. The lack of effect is supported by existing evidence 267 
from human clinical trials on the effect of hypothermia on kidney function [2], even though 268 
the nephroprotective effects of pre-ischemic, locally applied hypothermia are well established 269 
[11, 12]. Compared to isolated renal hypothermia, the physiological and biochemical effects 270 
of systemic hypothermia on renal function are more complex, and increased systemic 271 
vasoconstriction and volume depletion may reduce renal blood flow in a way that offsets the 272 
positive effects of hypothermia on metabolic demand and oxygen consumption. Even if there 273 
is equipoise on the effects of TTM on renal function after cardiac arrest, there is some 274 
evidence that it may be influenced by how TTM is performed. A recent observational trial 275 
found that prolonging the rewarming phase from 33 to 36 C to over 600 minutes resulted in 276 
less AKI and a lower release of the pro-inflammatory cytokine uIL-18, which is an early 277 
biomarker of AKI [13]. We found a significant difference in sCr trajectories for the two 278 
groups. After 24 hours of TTM (Day 1), there was sharp increase in sCr in the 24-hour 279 
cooling group during the rewarming phase. A similar increase in sCr was observed between 280 
days 2 and 3 during the rewarming phase of the 48-hour cooling group, suggesting that the 281 
reduced sCr observed during TTM is temporary and is reversed as patients become 282 
normothermic. The cause of the reduced sCr frequently observed during TTM is not clear, 283 
although a temporary reduction in creatinine production has been proposed [14]. Fluid 284 
administration may also dilute sCr, but the sharp increases in sCr during the rewarming phase 285 
were found despite daily positive fluid balances in both groups. 286 










In our study, 45.5% of the patients developed AKI. Incidences of AKI 1–3 in recent 288 
studies of OHCA patients admitted to the ICU ranges from 39 to 53% [1]. Although the 289 
KDIGO AKI definitions are now almost universally accepted, there are still variations in how 290 
AKI is defined since data on hourly UO are lacking in many studies including ours, leading to 291 
a potential underreporting of actual AKI when UO is omitted [15]. In the present study, we 292 
modified the UO criteria to be able to include daily UO and thereby increase the sensitivity of 293 
our AKI staging. In contrast to several earlier studies, we did not exclude patients who died 294 
within the first 48 hours, but in this period only five patients died, of which three developed 295 
AKI. RRT was uncommon in our study, as it was only used in 6.9% of the patients. This is 296 
low compared to the numbers reported in a 2016 systematic review where RRT utilisation 297 
ranged from 18 to 60% in seven studies on general cardiac arrest patients [1]. However, in 298 
two recent studies from Nordic countries, where most of the patients in our trial were 299 
recruited, the use of RRT was between 6 and 9% [16, 17]. Several factors, such as decisions 300 
to withhold RRT due to futility, local treatment preferences and the lack of consensus on RRT 301 
initiation criteria, are likely to have an impact on the prevalence of RRT utilisation [18]. It is 302 
worth noting that future studies might be influenced by the recent shift in evidence towards a 303 
more conservative approach in RRT initiation [19]. 304 
Studies on risk factors of AKI after cardiac arrest have identified age, rhythm, time to 305 
ROSC and higher doses of epinephrine as independent prognostic factors in the development 306 
of AKI [1, 20, 21]. In our study, we also found BMI to have significant effect, which is in 307 
accordance with several other studies that have identified obesity as an independent factor for 308 
AKI in critically ill and post-operative patients [22, 23]. The pathophysiology behind obesity 309 
related AKI still being explored. However, as obesity can be regarded as a state of low-grade 310 
inflammation, pro-inflammatory cytokines and adipokines as well as endothelial dysfunction 311 
may be involved. In addition, the direct physiological effects of overweight may include intra-312 
abdominal hypertension and cardiac dysfunction that might alter renal perfusion [24].  313 
As in previous studies, we found AKI to have a negative impact on survival, although 314 
this did not reach statistical significance in the group with AKI class 1 in the Cox regression 315 
analysis. It is still unclear whether the presence of AKI either has an independent effect on 316 
prognosis after cardiac arrest or this is due to unmeasured confounders [25]. Prolonged 317 
hypoperfusion and subsequent reperfusion injury does cause organ injury, but even after 318 
adjusting for classical markers of peri-arrest hypoperfusion, such as non-shockable rhythm, 319 
prolonged resuscitation and lack of bystander CPR, AKI was still a strong predictor of short- 320 









and long-term mortality. Post-resuscitation shock has been shown to be a strong predictor of 321 
the development of AKI and mortality [21, 26, 27], but the present study does not include data 322 
on the hemodynamic stability of the patients during the ICU stay, as we only considered 323 
factors present on admission in our analysis. 324 
 325 
Strengths and limitations 326 
The multicentre design and data collection of creatinine and UO for up to seven days 327 
within the context of a randomised controlled trial is a major strength of our study and 328 
increases the validity of our findings. Nonetheless, several limitations are worth mentioning.  329 
Since we did not have access to hourly UO data, using the original KDIGO AKI urine output 330 
criteria was not possible. It may be that our ability to include UO criteria only in AKI classes 331 
2 and 3 may have led to an underestimation of the number of patients in the AKI class 1 332 
group, as this group was relatively small compared to another study where hourly urine data 333 
were available [17].  334 
We did not have preadmission creatinine available and estimated our baseline creatinine using 335 
the MDRD equation as proposed by the KDIGO AKI guideline[7]. Since we did not have data 336 
on chronic kidney disease (CKD) except chronic dialysis in our study, this may have led to an 337 
overestimation of AKI. In a recent study of OHCA patients, 4% of the patients had previously 338 
known CKD [17]. The question of whether to use admission creatinine or estimated creatinine 339 
as a baseline has not been resolved, and studies have shown that up to 50% are misclassified 340 
with both approaches [28]. However, in their study of cardiac arrest patients, Geri et al. 341 
performed a sensitivity analysis of admission creatinine versus estimated creatinine and found 342 
similar results [20]. In our study, admission creatinine was missing in a large number of 343 
patients and in patients who did have an admission creatinine available, we saw a significant 344 
increase to the first creatinine available in the ICU, leading us to conclude that the latter was 345 
not a reasonable substitute for pre-morbid or admission creatinine. The validity of our 346 
findings was strengthened by an analysis of the 144 patients who did have sCr available 347 
before ICU admission. In this analysis, provided in Supplemental Table 2, there were only 348 
small differences in AKI classifications based on admission sCr compared to the classification 349 
based on estimated sCr. The patients cooled for 24 hours had a shorter length of stay than 350 
those cooled for 48 hours. Since we did not collect creatinine or urinary data after ICU 351 
discharge, it is possible that this could have influenced our results. However, it is likely that 352 
only the most stable ICU patients were discharged early from the ICU. 353 
 354 











We did not find any association between prolonged TTM at 33°C and the risk of AKI during 357 
the first seven days in the ICU. AKI is prevalent after cardiac arrest and TTM and occurs in 358 
almost half of all ICU admitted patients and more commonly in the elderly, with an increasing 359 
BMI and longer arrest duration. AKI after cardiac arrest is an independent predictor of time to 360 
death. 361 
 362 
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Table 1 518 








 No. (%) of Patients  
 No AKI  AKI   
Demographic characteristics    
Age (SD), y 58.0 (12.4) 63.0 (10.5) <0.001 
Male sex 157 (82.6) 133 (83.6) 0.801 
BMI, mean (SD), kg/height2 26.3 (3.7) 28.3 (5.3) <0.001 
    
Medical history    
Diabetes mellitus 23 (12.2) 39 (24.5) 0.003 
Previous acute myocardial infarction 27 (14.3) 27 (17.2) 0.457 
Chronic heart failure (NYHA class IV) 8 (4.2) 9 (5.7) 0.620 
Liver cirrhosis 1 (0.5) 2 (1.3) 0.592 
    
Arrest witnessed   0.894 
Bystander 161 (84.7) 137 (86.2)  
Emergency medical services 12 (6.3) 10 (6.3)  
Unwitnessed 17 (8.9) 12 (7.5)  
    
Resuscitation factors    
Bystander-initiated CPR 162 (85.3) 130 (81.8) 0.378 
Shockable rhythm 172 (90.9) 138 (87.1) 0.270 
Time to basic life support, median (IQR), 
min 
1 (2) 1 (1) 0.663 
Time to advanced life support, median 
(IQR), min 
8 (6) 8 (6) 0.333 
Time to return of spontaneous circulation, 
median (IQR), min 
19 (10) 22 (15) <0.001 
Epinephrine 106 (55.8) 112 (70.4) 0.005 
Amiodarone 66 (34.7) 77 (48.4) 0.010 
    
Immediate interventional cardiology    
Coronary angiography 160 (84.2) 128 (80.5) 0.364 
Percutaneous intervention 81 (42.6) 63 (40.1) 0.637 
    
Clinical status on ICU admission    
Temperature, mean (SD) ˚C 34.8 (0.9) 34.8 (1.1) 0.416 
Lactate, median (IQR), mmol/l 1.7 (1.9) 3.1 (5.4) 0.006 
Creatinine, mean (SD), µmol/l 92.0 (23.6) 117.0 (35.6) 0.003 
pH, mean (SD) 7.28 (0.1) 7.24 (0.1) 0.025 
Mean arterial pressure, mean (SD), mmHg 77.9 (14.5) 75.4 (17.5) 0.739 
    
48-hour cooling 92 (53.2) 81 (45.6) 0.639 










Fig 2. Cumulative number of patients developing AKI according to the KDIGO criteria in 528 

































Table 2 Results of the logistic regression analysis of admission factors predicting the 553 
development of AKI in post-cardiac arrest patients treated with TTM. 554 
 555 
 556 
 OR (95% CI) p-value 
Age 1.03 (1.01-1.06) 0.008 
BMI 1.10 (1.04-1.17) 0.001 
Diabetes mellitus 0.77 (0.40-1.50) 0.435 
Time to ROSC 1.03 (1.01-1.06) 0.011 
Adrenaline given 1.10 (0.63-1.97) 0.721 
Amiodarone given  1.28 (0.74-2.21) 0.375 
Lactate at admission 1.00 (0.91-1.11) 0.958 
pH at admission 0.15 (0.06-3.75) 0.250 
Creatinine at admission 1.02 (1.01-1.03) 0.000 


























Age 1.05 (1.03-1.07) <0.001 1.04 (1.02-1.07) <0.001 
Male 1.55 (0.98-2.47) 0.06 1.56 (0.96-2.53) 0.07 
Bystander CPR 1.88 (1.21-2.93) 0.01 1.50 (0.92-2.45) <0.001 
Time to ROSC 1.01 (1.01-1.02) <0.001 1.01 (1.00-1.01) 0.02 
Shockable rhythm 2.88 (1.81-4.58) <0.001 2.52 (1.50-4.23) <0.001 
KDIGO AKI 1 1.47 (0.75-2.88) <0.001 1.33 (0.66-2.66) 0.43 
KDIGO AKI 2 3.07 (1.83-5.13) <0.001 3.00 (1.73-5.19) <0.001 
KDIGO AKI 3 4.37 (2.61-7.33) <0.001 2.34 (1.27-4.32) 0.01 



















Table 4 Outcome and resource use in patients with various degrees of AKI during their ICU 583 














Resource use      
   Time on mechanical 
ventilation (hours) 
86 (62-130) 75 (60-122) 114 (48-144) 130(80-189) 0.02 
   ICU length of stay 
(hours) 
119 (78-178) 80 (64-128) 134 (72-229) 188(133-269) 0.013 
   Hospital length of stay 
(days) 





Suppl. Table 1. Development of markers of renal function during the first 72 hours. 590 
 All patients 24-hour cooling 48-hour cooling p-value 
First available creatinine* 101.8 (32.9) 104.2 (37.1) 99.5 (27.6) 0.193 
Est. Baseline creatinine** 92.3 (8.9) 91.0 (9.5) 91.5 (8.3) 0.558 
Creatinine     
   24-hours 95.9 (54.1) 96.7 (50.6) 95.0 (57.5) 0.78 
   48-hours 107.4 (70.6) 115.3 (77.8) 100.3 (62.6) 0.059 
   72-hours 121.6 (87.5) 126.6 (96.1) 117.2 (79.2) 0.367 
Urea     
   24-hours 7.9 (5.2) 8.0 (4.5) 7.7 (5.9) 0.851 
   48-hours 7.7 (6.5) 7.8 (5.3) 7.5 (7.6) 0.761 
   72-hours 8.2 (7.2) 9.2 (8.0) 7.4 (6.4) 0.039 
Urine output     
   24-hours 2294 (1232) 2368 (1329) 2220 (1123) 0.262 
   48-hours 2154 (1070) 2182 (1769) 2128 (10699 0.459 
   72-hours 2554 (1292) 2424 (1248) 2655 (1319) 0.145 
Daily fluid balance     
   24-hours 2294 (1232) 1585 (2106) 1667 (2033) 0.713 
   48-hours 1087 (1674) 888 (1769) 1276 (1562) 0.033 
   72-hours 333 (1768) 307 (1713) 354 (1814) 0.828 
 *First available serum creatine from hospital to ICU admission 591 



















Suppl. Fig 1 Survival of patients alive at day 4 after cardiac arrest with or without AKI 602 













































Fig 3. Serum creatinine over the first seven days in patients treated with either 24 or 48 hours 639 











































Suppl. Table 2. KDIGO AKI classification based on first available serum creatinine before 674 
ICU admission or estimated baseline serum creatinine at hospital admission. 675 
 676 
KDIGI AKI  First sCr No.(%) Est. sCr* No.(%) 
0 78 (54.2) 77 (53.5) 
1 15 (10.4) 9 (6.3) 
2 19 (13.2) 25 (17.4) 
3 32 (22.2) 33 (22.9) 
Total 144 (100) 144 (100) 
 677 
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